Norac Pharma

Executive Summary

Norac Pharma, founded in 1978 and based in Azusa, California, is a private contract development and manufacturing organization (CDMO) specializing in small molecule drug delivery. The company has established itself as a reliable partner for preclinical and early-stage pharmaceutical development, offering kilo lab and manufacturing services. Recent highlights include receiving a SOCMA National Performance Improvement Award for environmental, health, and safety achievements, and the dedication of a new kilo lab (KL-5) facility, reflecting ongoing capacity expansion. As a private entity with no disclosed pipeline or financials, Norac Pharma’s growth is driven by client engagements and service expansions. The company’s presence at industry events like Informex indicates active pursuit of new partnerships. With a focus on quality and performance, Norac Pharma is well-positioned to capture demand from small-molecule innovators seeking agile CDMO support.

Upcoming Catalysts (preview)

• TBDNew manufacturing contracts from biotech clients70% success
• TBDPotential expansion of analytical or formulation services60% success
• TBDRecognition or certification from regulatory bodies or industry groups80% success